Lab-Grown Bladder Models Reveal How E. coli Survives Antibiotics in Tissue
New research using 3D human bladder models shows that E. coli bacteria can survive antibiotic treatment by hiding in deeper tissue layers. This 'persister' state explains why urinary tract infections (UTIs) often recur despite successful initial treatment. The findings suggest that urine tests may miss bacteria embedded in the bladder wall, challenging current diagnostic and treatment approaches for recurrent infections.
Key points
- UTIs affect over 400 million people globally each year, with approximately 25% of adult women experiencing a recurrence within six months of an initial infection.
- Researchers in Switzerland and Germany developed a 3D 'mini-bladder' model using human cells to study how E. coli behaves during and after antibiotic treatment.
- The study found that E. coli can penetrate deep into bladder tissue and survive fosfomycin treatment by entering a temporary state without a normal cell wall, which the antibiotic targets.
- A separate UK study using a similar microtissue model found that nitrofurantoin, a common first-line UTI antibiotic, failed to eradicate bacteria associated with the bladder tissue in these models, despite performing well in standard lab tests.
- Prolonged exposure to concentrated urine was found to weaken connections between bladder cells, making the tissue more vulnerable to bacterial invasion and reducing antibiotic effectiveness.
- Women are disproportionately affected due to anatomical factors, including a shorter urethra and proximity of the urethral opening to the anus, as well as hormonal changes after menopause that reduce protective bacteria.
Background
This research builds on previous findings regarding recurrent UTIs, such as the September 2026 study showing that the drug OM-89 can boost bladder cell lysosomes to clear hidden E. coli. It also aligns with broader trends in using lab-grown organoids, like the brain organoids studied in August 2026, to understand human biology in controlled environments. The current study adds a new dimension by focusing on the physical and chemical conditions within the bladder that facilitate bacterial persistence.
Why it matters
Understanding how bacteria hide in bladder tissue could lead to more effective treatments and diagnostics for recurrent UTIs, which are a significant global health burden. It highlights the limitations of current urine-based tests and antibiotics, potentially guiding the development of new therapies that target bacteria within the tissue itself rather than just in the urine. This could reduce the reliance on long-term antibiotics, which contributes to antimicrobial resistance, a growing threat to global health according to the World Health Organization.
What to watch
Researchers will likely continue to refine these 3D bladder models to test new treatments, including bacteriophages, which showed some promise in reducing bacterial clusters but did not consistently outperform antibiotics alone in the UK study. Clinical trials may eventually be needed to validate these findings in human patients. Additionally, further research may explore how to strengthen bladder cell connections or develop antibiotics that can target bacteria in their 'persister' state.
Want the full story? Read the original reporting
Read on The Conversation